This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on September 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Illumina DRAGEN Tier 3 Throughput License and v4 Server
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Undiagnosed Diseases Program is seeking to procure an Illumina DRAGEN Server v4 and a corresponding Tier 3 500,000 Gb annual throughput license under solicitation 75N98026Q01167. This acquisition is critical to replace a legacy 2017 server that has reached end-of-support and lacks the hardware capabilities to run modern pangenome references and improved variant calling workflows. The new system is essential for the secure, high-performance secondary analysis of whole-genome, whole-exome, and transcriptome next-generation sequencing data, ensuring the program maintains NIH IT security compliance and mission-critical genomic interpretation capacity. This is a sole-source procurement under FAR 13.106-1(b)(1), identifying Illumina, Inc. as the only provider capable of meeting the proprietary FPGA-accelerated architecture requirements. The contract requires delivery and verification of the hardware and throughput access within 30 days of the award at the UDP Translational Laboratory in Rockville, Maryland. Evaluation for the award will be based on technical capability, price, and past performance, with invoicing conducted on a monthly basis.
General Info
Place of Performance
Bethesda, MD, 20814, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The NHGRI Undiagnosed Diseases Program (UDP) requires both the Illumina DRAGEN 500,000Gb annual throughput license and the Illumina DRAGEN Server v4 to maintain secure, compliant, and high performance secondary analysis of next generation sequencing (NGS) data. DRAGEN serves as an essential computational supplement when UDP’s sequencing workload exceeds CIT High Performance Computing Center allocations, enabling timely processing of whole genome, whole exome, and transcriptome datasets for patients with rare and unresolved diseases. The current DRAGEN server, procured in 2017, has reached end of support. Its CentOS 7 operating system lost vendor support and security updates on June 30, 2024, increasing operational risk. In addition, the legacy dual Intel Xeon processors, 512 Gb RAM, and first generation FPGA acceleration hardware cannot support updated DRAGEN pipelines, including pangenome references and improved germline/somatic variant calling workflows. These limitations reduce analytical accuracy, throughput, and system stability. To prevent analysis delays, maintain compliance with NIH IT security requirements, and sustain mission critical genomic interpretation capacity, the UDP must acquire both the updated throughput license and the next generation DRAGEN Server v4.
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
